Dr. Isaac Ciechanover Picks Up $38.5 Million in Series B Venture Funding For Atara Biotherapeutics

– The funding will be used by Dr. Ciechanover in the development of drugs for the treatment of Kidney disorders as well as Ovarian Cancer. – – Dr. Isaac Ciechanover, CEO  of Atara Biotherapeutics More...